Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Zhinan Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9680-4684; OpenAlex author ID A5059059453. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. High Level of Adropin Promotes the Progression of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.2174/0115680096267203231024093601↗
  2. Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer. First author DOI 10.1155/2021/5589342↗
  3. CIRBP Knockdown Attenuates Tumourigenesis and Improves the Chemosensitivity of Pancreatic Cancer via the Downregulation of DYRK1B. Co-author DOI 10.3389/fcell.2021.667551↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ji-Long Hu · 2 shared papers, 2021–2024 · strength 0.41
  2. Sanqing Jin · 1 shared paper, 2021 · strength 0.17
  3. Xiang Chen · 1 shared paper, 2021 · strength 0.17
  4. Chuanjun Chen · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.